文献速递角膜与眼表疾病青光眼

伊洛马司他-环糊精滴眼液制剂治疗眼部瘢痕

An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

本研究开发了含伊洛马司他与2-羟丙基-β-环糊精的滴眼液,伊洛马司他-CD在水中的溶解度约为1000 μg/mL、在PBS中为1400 μg/mL,均高于伊洛马司他单用;体外抑制胶原收缩活性与未复合伊洛马司他相比无变化;兔眼局部给药后巩膜、结膜和房水中可达治疗浓度。

要点

  • 伊洛马司他-CD在水中的溶解度约为1000 μg/mL,在PBS中为1400 μg/mL,高于伊洛马司他单用的140和160 μg/mL。
  • 体外抑制人Tenon成纤维细胞胶原收缩的活性与未复合伊洛马司他相比无变化。
  • 兔眼局部滴用后巩膜、结膜和房水中可达治疗浓度的伊洛马司他。

核心结论

  • 伊洛马司他-CD有潜力配制成抗纤维化滴眼液,可能对多种情况下的瘢痕预防有意义,例如青光眼滤过手术。

研究设计与样本

  • 本研究为实验性研究,采用2-羟丙基-β-环糊精在水溶液中配制伊洛马司他-CD,并开展体外、离体渗透及兔眼在体实验。

主要发现

  • 伊洛马司他-CD在水中的溶解度约为1000 μg/mL,在PBS(pH 7.4)中为1400 μg/mL,高于伊洛马司他单用(水140 μg/mL、PBS 160 μg/mL)。
  • 在人Tenon成纤维细胞存在下,伊洛马司他-CD体外抑制胶原收缩的活性与未复合伊洛马司他相比无变化。
  • 兔眼局部给予伊洛马司他-CD后,巩膜、结膜和房水中存在治疗浓度的伊洛马司他。

关键数值与推荐

  • 伊洛马司他-CD在水中的溶解度约为1000 μg/mL,在PBS(pH 7.4)中为1400 μg/mL。
  • 伊洛马司他单用在水中的溶解度为140 μg/mL,在PBS中为160 μg/mL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to develop a topical matrix metalloproteinase inhibitor preparation for antiscarring therapy. METHODS: The broad spectrum matrix metalloproteinase inhibitor ilomastat was formulated using 2-hydroxypropyl-β-cyclodextrin in aqueous solution. In vitro activity of ilomastat-cyclodextrin (ilomastat-CD) was examined using fibroblasts seeded in collagen. Permeation of ilomastat-CD eye drop through pig eye conjunctiva was confirmed using Franz diffusion cells. Ilomastat-CD eye drop was applied to rabbit eyes in vivo, and the distribution of ilomastat in ocular tissues and fluids was determined by liquid chromatography-mass spectroscopy. RESULTS: The aqueous solubility of ilomastat-CD was ∼1000 μg/mL in water and 1400 μg/mL in PBS (pH 7.4), which is greater than ilomastat alone (140 and 160 μg/mL in water and PBS, respectively). The in vitro activity of ilomastat-CD to inhibit collagen contraction in the presence of human Tenon fibroblast cells was unchanged compared to uncomplexed ilomastat. Topically administered ilomastat-CD in vivo to rabbit eyes resulted in a therapeutic concentration of ilomastat being present in the sclera and conjunctiva and within the aqueous humor. CONCLUSIONS: Ilomastat-CD has the potential to be formulated as an eye drop for use as an antifibrotic, which may have implications for the prevention of scarring in many settings, for example glaucoma filtration surgery.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Mohamed-Ahmed AHA, Lockwood A, Li H, et al. An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring. Invest Ophthalmol Vis Sci. 2017. PMID: 28692737. doi:10.1167/iovs.16-21377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。